Drugs stocks
The 822 US-listed companies classified as drugs (SIC group 283), largest first.
Prices as of Oct 30, 2026
Market value
$5.84T
822 companies
Year to date
−18.3%
On the day +1.36%
Over 52 weeks
−10.1%
Weighted by market value
P/E
65.4×
Net margin 10.4%
Drugs companies
The 200 largest of 812, ranked by market cap at the latest close. Revenue, margin and P/E use the last twelve months.
| # | Company | Market cap | Price | 1D | YTD | 1Y | Revenue | Net margin | P/E |
|---|---|---|---|---|---|---|---|---|---|
| 1 | $1.33T | $1,417.54 | +3.19% | +31.90% | +67.86% | $86.46B | 31.9% | 48.4× | |
| 2 | $658.38B | $273.20 | −0.73% | +32.01% | +44.51% | $97.93B | 21.5% | 31.3× | |
| 3 | $521.11B | $294.89 | +1.41% | +29.06% | +29.22% | $64.39B | 9.8% | 82.6× | |
| 4 | $361.02B | $146.33 | +3.83% | +39.02% | +69.01% | $66.57B | 4.8% | 113.8× | |
| 5 | $251.94B | $466.01 | +1.15% | +42.38% | +59.59% | $38.10B | 23.0% | 28.8× | |
| 6 | $211.64B | $170.68 | +3.06% | +39.06% | +44.11% | $30.46B | -10.6% | – | |
| 7 | $183.77B | $106.20 | +1.56% | −15.24% | −14.82% | $46.59B | 11.6% | 33.9× | |
| 8 | $178.60B | $40.00 | +2.20% | −21.38% | −20.06% | – | – | – | |
| 9 | $170.71B | $29.95 | +1.70% | +20.28% | +23.30% | $63.70B | 6.8% | 39.4× | |
| 10 | $141.65B | $558.88 | +3.50% | +23.28% | +33.10% | $12.59B | 35.0% | 32.2× | |
| 11 | $127.63B | $62.48 | +1.78% | +15.83% | +36.96% | $50.03B | 18.5% | 13.8× | |
| 12 | $108.14B | $44.34 | +2.81% | −8.50% | −12.96% | – | – | – | |
| 13 | $106.83B | $49.51 | +1.71% | +0.96% | +5.48% | – | – | – | |
| 14 | $95.53B | $927.89 | +13.33% | +20.21% | +41.87% | $16.90B | 28.5% | 19.8× | |
| 15 | $88.52B | $221.72 | −0.47% | +651.8% | +687.9% | $2.23B | -141.4% | – | |
| 16 | $72.06B | $20.91 | +4.50% | +34.12% | +58.05% | – | – | – | |
| 17 | $48.32B | $41.47 | +3.75% | +32.87% | +105.0% | $14.10B | 5.0% | 68.4× | |
| 18 | $43.42B | $551.21 | −4.30% | −18.52% | −12.30% | $4.55B | 25.0% | 38.1× | |
| 19 | $42.11B | $370.33 | −0.33% | +21.90% | +20.15% | $6.13B | 10.7% | 64.2× | |
| 20 | $41.00B | $191.31 | +0.55% | +140.2% | +225.0% | $0 | – | – | |
| 21 | $38.63B | $67.18 | +1.90% | +73.86% | +81.86% | $2.54B | 32.1% | 47.4× | |
| 22 | $37.47B | $253.62 | +1.59% | +44.11% | +69.52% | $10.03B | 8.3% | 44.9× | |
| 23 | $32.94B | $79.72 | +1.17% | −36.64% | −44.68% | $9.52B | 27.5% | 12.6× | |
| 24 | $26.66B | $36.91 | −1.63% | +70.09% | +88.51% | $7.53M | -3535.0% | – | |
| 25 | $25.68B | $598.72 | +0.87% | +22.88% | +32.01% | $3.15B | 41.6% | 19.6× | |
| 26 | $24.59B | $112.58 | +0.89% | −35.31% | −42.03% | $1.52B | -39.9% | – | |
| 27 | $22.15B | $88.17 | −1.08% | −7.38% | −15.76% | – | – | – | |
| 28 | $22.08B | $165.00 | −5.17% | −58.51% | −63.30% | $3.71B | 71.3% | 8.3× | |
| 29 | $21.86B | $19.04 | −0.86% | +52.89% | +83.74% | $14.74B | – | – | |
| 30 | $17.19B | $69.39 | +4.82% | +58.32% | +78.20% | $2.50B | 35.5% | 19.4× | |
| 31 | $15.57B | $251.27 | −0.68% | +17.83% | +23.35% | $1.17B | 70.8% | 18.7× | |
| 32 | $14.86B | $130.91 | −0.21% | +94.52% | +102.6% | $1.66B | 24.9% | 35.9× | |
| 33 | $14.85B | $146.10 | −0.19% | +3.01% | +5.84% | $3.37B | 20.9% | 21.1× | |
| 34 | $14.65B | $74.95 | +5.97% | −2.01% | +18.27% | $945.54M | – | – | |
| 35 | $14.39B | $92.24 | −5.45% | +123.6% | +147.4% | $840.85M | 9.6% | 178.5× | |
| 36 | $14.02B | $215.98 | +3.92% | +27.05% | +58.46% | $4.60B | 20.4% | 14.9× | |
| 37 | $12.79B | $16.03 | −1.05% | −8.35% | −14.00% | $0 | – | – | |
| 38 | $11.83B | $14.17 | +0.43% | +0.93% | +5.35% | – | – | – | |
| 39 | $11.52B | $23.06 | −0.77% | +1.90% | +2.17% | $5.02B | -4.0% | – | |
| 40 | $11.39B | $72.66 | −0.07% | +23.55% | +19.19% | $1.22B | 9.0% | 104.0× | |
| 41 | $11.33B | $58.51 | +1.77% | −1.55% | +12.71% | $3.41B | 2.1% | 155.2× | |
| 42 | $10.89B | $50.22 | −0.24% | +6.09% | +2.98% | – | – | – | |
| 43 | $10.53B | $126.63 | +3.29% | +62.74% | +106.1% | $102.24M | -341.8% | – | |
| 44 | $9.99B | $176.94 | −6.20% | +7.98% | +22.39% | $805.61M | -1.5% | – | |
| 45 | $9.94B | $430.36 | −0.31% | −26.10% | +0.66% | $1.28B | -25.3% | – | |
| 46 | $9.84B | $332.29 | +2.38% | +34.78% | +75.74% | $440.48M | 54.8% | 40.7× | |
| 47 | $9.58B | $152.78 | −11.92% | +381.7% | +390.2% | $431.80M | -31.7% | – | |
| 48 | $9.37B | $144.85 | +0.35% | +65.85% | +86.06% | $281.99M | 29.4% | 113.1× | |
| 49 | $9.36B | $61.18 | +5.34% | +105.2% | +79.84% | $799.54M | 55.2% | 21.2× | |
| 50 | $9.23B | $62.03 | −0.93% | +34.44% | +38.61% | – | – | – | |
| 51 | $8.79B | $8.29 | −5.15% | +318.7% | +251.3% | $165.79M | -598.6% | – | |
| 52 | $8.77B | $81.12 | −5.62% | +133.1% | +12.26% | $830.81M | 6.6% | 158.9× | |
| 53 | $8.76B | $62.99 | −0.51% | −0.87% | +1.19% | $67.67M | -1321.1% | – | |
| 54 | syreSpyre Therapeutics | $8.51B | $96.56 | −2.43% | +194.7% | +298.0% | $0 | – | – |
| 55 | $8.46B | $59.90 | −0.98% | −9.78% | +41.57% | $669.50M | -47.8% | – | |
| 56 | $7.98B | $285.93 | −0.93% | −2.99% | +42.25% | $0 | – | – | |
| 57 | $7.61B | $45.34 | −0.07% | +62.04% | +47.11% | $1.67B | 4.0% | 115.0× | |
| 58 | $7.57B | $144.43 | +0.68% | −20.92% | +8.47% | $776.57M | -24.7% | – | |
| 59 | $7.23B | $43.52 | −1.96% | −44.99% | −41.32% | $874.09M | -64.7% | – | |
| 60 | $6.87B | $21.51 | +0.75% | +70.71% | +115.1% | $3.12B | 5.0% | 43.7× | |
| 61 | $6.80B | $86.59 | −2.77% | −35.79% | −16.97% | – | – | – | |
| 62 | $6.56B | $100.46 | +0.14% | +50.95% | +81.04% | $1.56B | 17.7% | 23.8× | |
| 63 | $6.43B | $322.75 | +1.71% | +70.70% | +72.54% | $253.83M | 20.3% | 125.0× | |
| 64 | $6.41B | $96.87 | +0.23% | +219.6% | +244.6% | – | – | – | |
| 65 | $6.37B | $92.57 | −0.54% | −13.52% | −17.21% | $239.92M | -85.6% | – | |
| 66 | $6.23B | $99.18 | −1.22% | +254.7% | +371.2% | – | – | – | |
| 67 | $6.09B | $154.74 | +2.97% | −3.26% | +57.74% | – | – | – | |
| 68 | $6.03B | $29.17 | −1.59% | +14.75% | +17.53% | – | – | – | |
| 69 | $5.84B | $139.69 | −2.89% | – | – | – | – | – | |
| 70 | $5.73B | $64.68 | +1.91% | +55.78% | +52.30% | $6.23M | -3602.7% | – | |
| 71 | $5.52B | $85.00 | −1.61% | +7.61% | +17.73% | $618.07M | -139.2% | – | |
| 72 | $5.38B | $31.02 | −2.94% | −12.67% | +91.36% | – | – | – | |
| 73 | $5.35B | $43.90 | −0.63% | −0.34% | +49.47% | $0 | – | – | |
| 74 | $5.07B | $10.38 | −2.90% | −95.81% | −94.64% | $53.29M | -235.0% | – | |
| 75 | $5.02B | $14.35 | −4.21% | +285.8% | +483.3% | – | – | – | |
| 76 | $5.01B | $59.97 | −6.97% | −21.05% | −11.95% | $1.16B | -9.2% | – | |
| 77 | $4.97B | $51.42 | −5.23% | −1.95% | −15.84% | $13.39M | -3368.7% | – | |
| 78 | $4.88B | $36.33 | −4.29% | +171.3% | +171.3% | – | – | – | |
| 79 | $4.75B | $50.39 | −0.36% | +31.88% | +69.95% | $591.33M | -7.4% | – | |
| 80 | dnthDianthus Therapeutics | $4.61B | $82.38 | −0.39% | +99.90% | +144.2% | $2.04M | -9442.3% | – |
| 81 | $4.25B | $26.64 | −5.43% | +64.04% | +57.54% | $308.08M | -20.7% | – | |
| 82 | $4.22B | $38.90 | −0.03% | +56.76% | +108.4% | – | – | – | |
| 83 | $4.17B | $35.37 | +0.34% | −1.42% | +21.42% | $1.37B | 32.8% | 9.3× | |
| 84 | $4.03B | $45.06 | +0.16% | +30.65% | +94.22% | $450.91M | 30.7% | 29.1× | |
| 85 | $4.03B | $32.07 | +0.31% | +10.43% | +28.69% | $463.98M | 6.1% | 141.3× | |
| 86 | $4.02B | $18.35 | −5.75% | +116.9% | +150.0% | $10.35M | -2763.6% | – | |
| 87 | $4.00B | $21.63 | −3.00% | −0.51% | −32.93% | $1.27B | -17.2% | – | |
| 88 | $3.84B | $8.48 | −11.30% | +210.6% | +334.9% | $324.97M | -89.1% | – | |
| 89 | $3.83B | $22.72 | +0.84% | +156.4% | +185.1% | $53.81M | -229.9% | – | |
| 90 | bgmBGM | $3.83B | $9.54 | 0.00% | −91.38% | −96.51% | – | – | – |
| 91 | $3.76B | $12.27 | −6.19% | +258.8% | +128.9% | $66.17M | -248.8% | – | |
| 92 | $3.63B | $13.84 | +0.22% | +93.03% | +110.7% | $6.10B | 3.5% | 17.1× | |
| 93 | $3.62B | $37.41 | −0.35% | −16.53% | −12.33% | $0 | – | – | |
| 94 | $3.55B | $20.59 | −0.82% | −22.91% | −9.45% | $1.14B | 33.4% | 9.3× | |
| 95 | $3.50B | $28.32 | −1.32% | – | – | – | – | – | |
| 96 | $3.43B | $22.07 | −1.30% | +25.11% | −13.52% | $449.61M | -41.9% | – | |
| 97 | $3.32B | $6.71 | −2.19% | −68.05% | −58.96% | – | – | – | |
| 98 | $3.28B | $74.85 | +0.88% | −8.59% | +8.54% | $606.33M | -7.7% | – | |
| 99 | $3.24B | $44.25 | −1.84% | +187.3% | +84.61% | – | – | – | |
| 100 | $3.22B | $28.86 | +0.63% | +138.9% | +105.4% | $0 | – | – | |
| 101 | $3.18B | $27.28 | +1.56% | −22.46% | −28.53% | $0 | – | – | |
| 102 | $3.12B | $16.69 | −2.05% | −14.67% | −29.13% | – | – | – | |
| 103 | $3.10B | $80.84 | −2.41% | +1.80% | −5.73% | – | – | – | |
| 104 | $3.08B | $31.96 | −2.83% | −7.55% | +1.14% | $234.13M | -74.8% | – | |
| 105 | $3.08B | $9.10 | −4.31% | +21.50% | −15.19% | – | – | – | |
| 106 | $3.07B | $8.20 | −7.97% | +17.99% | +24.05% | $10.85B | -10.1% | – | |
| 107 | $3.03B | $18.94 | −1.97% | +14.72% | +15.63% | $0 | – | – | |
| 108 | $2.81B | $27.23 | −5.58% | −1.77% | +14.41% | $156.04M | -54.7% | – | |
| 109 | $2.79B | $24.67 | −0.52% | −20.73% | +4.27% | $71.13M | -544.1% | – | |
| 110 | $2.78B | $8.10 | +0.75% | −13.37% | −11.57% | – | – | – | |
| 111 | $2.78B | $26.80 | −1.18% | +41.28% | +109.7% | $701.94M | 42.0% | 9.4× | |
| 112 | $2.69B | $55.87 | +2.44% | +77.14% | +156.4% | – | – | – | |
| 113 | $2.58B | $11.82 | −3.59% | +69.10% | +97.00% | $883.99M | -6.3% | – | |
| 114 | $2.56B | $11.41 | −2.89% | −37.45% | −25.28% | $512.28M | 33.0% | 15.1× | |
| 115 | $2.48B | $6.94 | +4.52% | +66.03% | +71.36% | – | – | – | |
| 116 | $2.44B | $41.92 | +0.19% | −15.65% | −25.81% | $865.11M | -5.1% | – | |
| 117 | $2.40B | $20.06 | −3.37% | −42.82% | −48.19% | $7.12M | -3644.2% | – | |
| 118 | $2.36B | $30.10 | +0.70% | +10.82% | +15.77% | $158.00K | -190220.9% | – | |
| 119 | $2.33B | $15.42 | −6.49% | +36.58% | −11.33% | – | – | – | |
| 120 | $2.32B | $49.06 | +0.64% | −20.47% | −18.60% | $1.10B | 15.6% | 13.5× | |
| 121 | $2.32B | $18.19 | −2.26% | −23.67% | −9.91% | $117.00M | -393.2% | – | |
| 122 | $2.29B | $13.15 | −3.24% | −1.35% | −8.87% | – | – | – | |
| 123 | $2.26B | $38.76 | +0.44% | +3.58% | +34.12% | $959.90M | 18.9% | 12.5× | |
| 124 | $2.23B | $30.98 | +1.47% | −38.82% | +4.42% | – | – | – | |
| 125 | $2.22B | $29.82 | +2.09% | +94.77% | +111.0% | $104.97M | -155.6% | – | |
| 126 | $2.22B | $16.65 | −3.25% | +4.39% | +37.38% | $321.74M | 97.7% | 7.0× | |
| 127 | $2.19B | $15.78 | −0.75% | +13.36% | −23.55% | $4.14B | -41.9% | – | |
| 128 | $2.19B | $33.53 | −0.15% | +20.83% | +50.76% | – | – | – | |
| 129 | $2.16B | $8.47 | −0.59% | +8.59% | +16.83% | $940.61M | -40.9% | – | |
| 130 | $2.16B | $4.03 | −4.95% | −1.47% | −28.67% | $54.86M | -945.9% | – | |
| 131 | $2.13B | $32.28 | −0.15% | −1.28% | +3.00% | – | – | – | |
| 132 | $2.11B | $146.15 | −3.58% | +39.63% | +86.37% | – | – | – | |
| 133 | $2.07B | $18.21 | −0.44% | −15.22% | +13.95% | $4.02M | -5593.8% | – | |
| 134 | $2.06B | $40.26 | −6.18% | +11.80% | +16.59% | $306.30M | 7.9% | 85.1× | |
| 135 | $2.05B | $44.00 | −2.72% | +57.82% | +104.7% | $98.88M | -24.5% | – | |
| 136 | $2.03B | $27.14 | −9.50% | +51.79% | +32.65% | $259.04M | -21.0% | – | |
| 137 | $2.03B | $28.61 | −0.35% | +8.66% | +49.63% | $37.13M | -404.0% | – | |
| 138 | $2.03B | $7.81 | −7.68% | +140.3% | +148.7% | $208.78M | -37.1% | – | |
| 139 | $1.98B | $10.28 | −3.02% | +18.30% | +48.34% | $1.14B | – | – | |
| 140 | $1.97B | $18.62 | −3.17% | −13.48% | −19.91% | $1.97B | -6.9% | – | |
| 141 | $1.97B | $15.16 | −3.25% | −15.96% | −7.73% | – | – | – | |
| 142 | $1.95B | $9.68 | −4.68% | +156.8% | +406.8% | – | – | – | |
| 143 | $1.95B | $10.71 | −0.37% | +36.43% | +10.30% | $335.41M | -5.1% | – | |
| 144 | $1.94B | $41.45 | +2.55% | – | – | – | – | – | |
| 145 | $1.93B | $13.56 | −1.81% | +8.31% | +21.40% | – | – | – | |
| 146 | $1.91B | $11.30 | −3.83% | +87.40% | +90.56% | $303.23M | -83.0% | – | |
| 147 | genbGenerate Biomedicines | $1.86B | $14.46 | −8.31% | – | – | – | – | – |
| 148 | $1.85B | $28.39 | −1.29% | −21.81% | −4.99% | $10.00M | -4843.8% | – | |
| 149 | $1.82B | $30.55 | −17.94% | +12.23% | −29.25% | $98.34M | -418.2% | – | |
| 150 | $1.75B | $31.48 | −1.41% | −24.02% | −5.24% | $167.50M | -79.8% | – | |
| 151 | $1.75B | $12.47 | −5.74% | +38.71% | +1.67% | $59.51M | -672.2% | – | |
| 152 | $1.72B | $24.83 | −1.86% | +3.76% | −63.41% | $18.67M | -1350.7% | – | |
| 153 | $1.70B | $26.29 | −0.23% | −17.17% | −17.07% | $27.59M | -753.6% | – | |
| 154 | $1.67B | $4.76 | −0.21% | −46.88% | −7.57% | $169.90M | -88.2% | – | |
| 155 | $1.67B | $12.86 | −4.10% | – | – | – | – | – | |
| 156 | nvaxNovavax | $1.66B | $10.08 | −3.72% | +50.00% | +19.57% | $413.80M | -59.9% | – |
| 157 | $1.66B | $17.61 | +1.27% | +81.17% | +71.80% | – | – | – | |
| 158 | $1.65B | $72.00 | −1.59% | −8.79% | −21.68% | $978.38M | 11.1% | 15.3× | |
| 159 | $1.61B | $45.08 | −0.32% | – | – | – | – | – | |
| 160 | $1.61B | $18.18 | −14.41% | −49.90% | −55.79% | – | – | – | |
| 161 | $1.60B | $11.57 | −5.09% | +67.68% | +83.65% | – | – | – | |
| 162 | $1.60B | $32.72 | −2.27% | +39.71% | +64.84% | $188.73M | -51.7% | – | |
| 163 | $1.59B | $16.10 | −4.05% | −30.00% | −54.22% | $717.21M | -81.7% | – | |
| 164 | $1.58B | $38.88 | +0.05% | +4.07% | −7.12% | $1.52B | 6.6% | 15.8× | |
| 165 | $1.57B | $30.49 | −2.49% | −12.16% | −5.28% | $430.78M | -4.2% | – | |
| 166 | $1.56B | $21.87 | −0.32% | −68.55% | −32.12% | – | – | – | |
| 167 | $1.53B | $21.22 | −0.42% | +6.15% | +18.22% | $440.00M | – | – | |
| 168 | $1.53B | $6.97 | −4.65% | −42.59% | −41.03% | $52.05M | -579.1% | – | |
| 169 | $1.52B | $31.37 | −7.19% | +35.68% | +70.12% | – | – | – | |
| 170 | $1.49B | $52.18 | −2.78% | +208.6% | +185.9% | $105.60M | 12.0% | 117.5× | |
| 171 | $1.47B | $49.24 | +5.64% | +52.35% | +113.3% | $237.61M | 82.4% | 7.5× | |
| 172 | $1.45B | $4.65 | −4.91% | −9.36% | −40.69% | – | – | – | |
| 173 | $1.45B | $36.39 | 0.00% | +40.61% | +71.09% | $746.16M | 2.0% | 99.1× | |
| 174 | $1.35B | $14.46 | −2.85% | −44.91% | −55.82% | – | – | – | |
| 175 | $1.35B | $4.13 | −2.13% | −24.91% | −15.89% | $5.49M | -2728.0% | – | |
| 176 | $1.33B | $18.44 | −2.69% | +7.37% | +145.2% | – | – | 10.7× | |
| 177 | $1.33B | $38.87 | −0.79% | −8.07% | −38.11% | $55.23M | -297.1% | – | |
| 178 | $1.33B | $21.49 | −2.36% | −6.61% | +192.4% | – | – | – | |
| 179 | $1.32B | $14.13 | −1.26% | – | – | – | – | – | |
| 180 | $1.29B | $20.86 | −2.98% | +64.25% | +66.35% | – | – | – | |
| 181 | $1.28B | $39.70 | −1.12% | +78.35% | +143.9% | – | – | – | |
| 182 | $1.26B | $21.07 | −1.91% | −19.86% | +34.38% | – | – | – | |
| 183 | $1.24B | $1.66 | 0.00% | +31.75% | +13.70% | $587.90M | -12.4% | – | |
| 184 | $1.22B | $13.65 | −3.53% | −35.03% | +1.94% | $252.25M | -87.5% | – | |
| 185 | $1.22B | $3.30 | −1.79% | +25.48% | +35.25% | $179.09M | 39.1% | 17.4× | |
| 186 | $1.20B | $25.05 | +3.47% | −17.44% | −6.81% | – | – | – | |
| 187 | amphAmphastar Pharmaceuticals | $1.18B | $27.72 | +2.93% | +3.51% | +12.41% | $730.02M | 10.8% | 15.0× |
| 188 | $1.16B | $19.68 | −5.88% | +50.46% | −21.28% | – | – | 0.9× | |
| 189 | $1.14B | $25.63 | −0.31% | +256200% | +256200% | – | – | – | |
| 190 | $1.13B | $3.50 | 0.00% | −38.27% | −36.94% | $393.63M | -11.1% | – | |
| 191 | $1.07B | $17.47 | −2.02% | +26.59% | −38.72% | $24.00M | -427.5% | – | |
| 192 | $1.06B | $28.24 | −5.84% | −42.37% | −24.81% | $275.59M | -13.5% | – | |
| 193 | $1.06B | $71.78 | −2.54% | −9.14% | −8.57% | $1.30M | -10629.3% | – | |
| 194 | sptxSeaport Therapeutics | $1.05B | $19.60 | −7.11% | – | – | – | – | – |
| 195 | $1.00B | $11.78 | −6.28% | −10.62% | +20.08% | – | – | – | |
| 196 | $990.32M | $4.82 | −2.63% | −20.07% | +12.09% | – | – | – | |
| 197 | $967.25M | $15.03 | −2.72% | +45.22% | +98.81% | – | – | – | |
| 198 | $965.31M | $7.20 | −1.50% | −31.43% | −30.90% | – | – | – | |
| 199 | $958.47M | $51.31 | −0.27% | +19.80% | +62.27% | $276.79M | 116.3% | 3.0× | |
| 200 | $957.75M | $9.24 | +2.78% | +12.96% | −30.73% | – | – | – |
Compare companies in the screener or browse all industries.